Skip to main content
. Author manuscript; available in PMC: 2017 Jul 1.
Published in final edited form as: Int J Cardiol. 2016 Apr 6;214:428–437. doi: 10.1016/j.ijcard.2016.03.215

Table 6.

Use of the CrossBoss catheter for procedures in which antegrade dissection and reentry was utilized.

Variable Overall CrossBoss Wire-based
techniques
only
Procedural
Characteristics and
Outcomes
n=458 n=246 n=212 p
In-stent restenosis (%) 13.5 15.9 10.6 0.10
IVUS used (%) 50.2 50.0 50.4 0.95
Stenting (%) 84.3 88.6 78.5 0.005
Number of stents* 2.9±1.1 2.9±1.1 3.0±1.2 0.48
Hemodynamic support
(LVAD) (%)
4.4 2.6 6.7 0.07
Fluoroscopy time (min)* 58.1 (37.2-87.1) 51.8 (31.4-80.4) 63.8 (44.1-97.5) <0.001
Patient air kerma dose
(Gray)*
4.1 (2.6-6.0) 3.9 (2.3-6.0) 4.2 (2.8-6.2) 0.06
Procedure time (min)* 156.5 (112.3-
216.8)
144.5 (103.5-
203.8)
175.5 (122.3-
235.3)
<0.001
Contrast volume (ml)* 310 (226-411) 300 (225-399) 340 (240-450) 0.03
Technical success (%) 86.9 89.8 83.5 0.045
Procedural success (%) 85.0 87.2 82.3 0.14
MACE (%) 2.9 3.7 1.9 0.40
Death (%) 0.4 0.4 0.5 >0.99
Myocardial infarction (%) 0.9 0.8 1.0 >0.99
Stroke (%) - - - -
Emergency re-PCI (%) 0.2 0.4 0 >0.99
Emergency CABG (%) - - - -
Emergency
pericardiocentesis (%)
1.8 2.5 1.0 0.30

CABG, coronary artery bypass graft surgery; IVUS, intravascular ultrasound; LVAD, left ventricular assist device; kerma, kinetic energy released per unit mass; MACE, major adverse cardiovascular events; PCI, percutaneous coronary intervention

*

mean±standard deviation or median (interquartile range).